<\/p>\n
Dorzox Eye Drop is Dorzolamide HCl 2%, a carbonic anhydrase inhibitor (CAI) eye drop that lowers eye pressure 18\u201322% by reducing aqueous humour production. Used three times daily as monotherapy or twice daily as add-on. Avoid in severe sulfa allergy.<\/p>\n<\/div>\n
\ud83d\udce6 Every order is covered by our Reshipment Assurance Policy<\/strong><\/a> \u2014 if your parcel does not arrive within 20 business days, we reship it.<\/p>\n Dorzox Eye Drop is sourced from a WHO-GMP certified manufacturer and shipped worldwide in plain, discreet packaging. Every order is covered by our Reshipment Assurance Policy<\/a> \u2014 if it has not arrived after 20 business days we reship at no extra cost. Backed by 1,400+ verified customer reviews.<\/p>\n Dorzox Eye Drop is manufactured by Cipla and contains Dorzolamide HCl 2% as a sterile ophthalmic clear solution. It is a topical carbonic anhydrase inhibitor used to lower IOP in glaucoma. Dorzolamide is a clear solution. Some patients report a transient bitter taste from drainage into the throat, and mild stinging from the acidic pH (pH 5.6).<\/p>\n Dorzolamide HCl blocks carbonic anhydrase isoenzyme II in the ciliary epithelium, slowing the formation of bicarbonate and the consequent flow of sodium and water into the posterior chamber. The result is reduced aqueous humour production and lower IOP. Topical CAIs reach significant intraocular concentration without the systemic side effects of oral acetazolamide (paraesthesia, kidney stones, taste disturbance).<\/p>\nWhy order from MedsBase<\/h3>\n
What is Dorzox Eye Drop?<\/h2>\n
How It Works<\/h2>\n
Indications & Dosing<\/h2>\n